The rationale of this study is to confirm and support the clinical safety and performance of any of these products in a real-world population of 209 patients who underwent an endovascular intervention within standard-of-care of the iliacofemoral artery and renal artery, using at least one of the investigational products from iVascular.
Corresponding to the CE-mark indications/contra-indications and according to the IFU of the device.
Patient is >18 years old.
Patient understands the nature of the procedure and provides written informed consent prior to enrollment in the study.
Target lesion(s) is/are located in renal, iliac or femoral arteries.
Anatomy or size of vessels that will not allow appropriate usage of the investigational devices, following IFU of the investigational devices.
Known contraindication and/or allergy to (a component of) an investigational device.
Pregnant women and women with childbearing potential not taking adequate contraceptives or currently breastfeeding.
Life expectancy of less than 12 months.
Every patient who is eligible for treatment with any of the following devices, can be considered to be included in the study: the Oceanus 18 Balloon Dilatation Catheter and/or the Oceanus 35 Balloon Dilatation Catheter and/or the Luminor 18 Drug Coated Balloon and/or the Luminor 35 Drug Coated Balloon and/or the Restorer Peripheral Stent System and/or the iVolution pro Peripheral Self-Expanding Stent System and/or the iCover Covered Peripheral Stent System and/or the Sergeant Peripheral Support Catheter
Cohort
Prospective
endovascular intervention
Procedure/Surgeryendovascular intervention
Freedeom from SAEs and SADEs (Primary Safety Endpoint)
Freedeom from SAEs and SADEs
Technical success rate (Primary Efficacy Endpoint)
Technical success rate defined as ability to cross, introduce and deploy devices based on quantitative scaling by investigators
General physician appraisal of the devices by means of rating scale
General physician appraisal of the devices will be explored based on: 1. Simplicity of handling, 2. Pushability, 3. Trackability, 4. Crossability and 5. Profile
General physician appraisal of the devices by means of rating scale for the Luminor 18, Luminor 35, Oceanus 18 and Oceanus 35
Physician appraisal for the Luminor 18, Luminor 35, Oceanus 18 and Oceanus 35 will be explored based on: 1. Deflation time, 2. Balloon Compliance, 3. Visibility and 4. Balloon refolding
General physician appraisal of the devices by means of rating scale for the Restorer, iVolution pro, iCover
Physician appraisal for the Restorer, iVolution pro, iCover be explored based on: 1. Recoil, 2. Radial force, 3. Ease to canalize the lesion, 4. Stent coverage, 5. Stent graft recrossing and 6. Balloon refusal
General physician appraisal of the devices by means of rating scale for the Sergeant
And physician appraisal for the Sergeant will be explored based on: 1. Trackability over the guide wire, 2. Absence of kinking behaviour, 3. Injection Capacity, 4. Ease of changing guide wires and 5. Ease to canalize the lesion
Click on the lead sponsor to view all of their trials.
